Abstract
No public abstract is available from the verified source records.
Daniel M. Gelfman
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
An approach to the older patient with a suspicion of HFpEF
10.1016/j.amjmed.2025.07.036 · 2026
Do patients who are over 60, obese, with atrial fibrillation, also have HFpEF?
10.1016/j.amjmed.2024.07.033 · 2024
Chlorthalidone as secondary treatment in HFpEF?
10.1016/j.amjmed.2024.09.027 · 2025
Heart failure with preserved ejection fraction: JACC scientific statement
10.1016/j.jacc.2023.01.049 · 2023
HFpEF and HFmrEF in acute heart failure: isolated diastolic dysfunction or alternative cardiac pathologies?
10.1007/s11739-025-04097-w · 2025
Mineralocorticoid receptor antagonist use in hypertension to prevent heart failure
10.1016/j.jchf.2025.02.021 · 2025
No additional external references are available.